Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Publications section updated to clarify PubMed-based data population and to note Revision: v3.3.2, replacing the prior v3.2.0 wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T23:29:25.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The general government funding/operating status notice was removed from the page.
    Difference
    0.2%
    Check dated 2025-11-19T22:14:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    - Location entry updated: 'Tainan City, Taiwan, 704' changed to 'Tainan, Taiwan, 704'.
    Difference
    0.0%
    Check dated 2025-11-12T18:46:43.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    No significant additions or deletions observed; the page content, including study details and location listings, appears unchanged aside from minor formatting and UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T10:10:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an important government-operating-status notice; v3.1.0 is removed.
    Difference
    3%
    Check dated 2025-10-07T23:19:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Version bump: replacing v3.0.2 with v3.1.0 in the page metadata.
    Difference
    0.1%
    Check dated 2025-09-30T02:41:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.